drugset
drugset / Trial / NCT03405441

A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male Participants

NCT03405441 ↗

Phase 1 Completed 42 enrolled Janssen Research & Development, LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to assess safety and tolerability of day-time and night-time dosing of JNJ-55375515 in healthy male participants.

Timeline

Start
2018-01-02
Primary completion
2018-09-04
Completion
2018-09-04

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-55375515 Unknown — Oral

Indications

No indication recorded.